API Acquisition by Wesfarmers on Track After Woolworths Withdraws
API Acquisition by Wesfarmers on Track After Woolworths Withdraws
By Stuart Condie
作者：斯圖爾特·康迪
SYDNEY--Australian Pharmaceutical Industries Ltd. said its acquisition by Wesfarmers Ltd. is on track for completion by the end of March after Woolworths Group Ltd. withdrew its 872 million Australian-dollar (US$624.9 million) proposal.
悉尼——澳大利亞製藥工業有限公司表示，在伍爾沃斯集團有限公司撤回其8.72億澳元（6.249億美元）的提案後，其對Wesfarmers Ltd.的收購有望在3月底之前完成。
API said its scheme implementation deed with Wesfarmers remained in place for the retail and industrial conglomerate to acquire the shares it doesn't already own for A$1.55 per security.
API表示，其與Wesfarmers的計劃實施協議仍然有效，該零售和工業集團可以以每隻證券1.55澳元的價格收購其尚未擁有的股份。
Woolworths had proposed A$1.75 per security but Wesfarmers had said it wouldn't vote its 19.3% stake in favor of a proposal by its retail rival.
伍爾沃斯曾提議每隻證券1.75澳元，但Wesfarmers曾表示不會將其19.3％的股份投票支持其零售競爭對手的提案。
Woolworths on Friday said it had withdrawn the proposal it made last month after conducting comprehensive due diligence on the pharmaceutical distributor and retailer. It said it couldn't be sure the financial return on the acquisition would be in-line with its capital allocation framework.
伍爾沃斯週五表示，在對這家藥品分銷商和零售商進行全面盡職調查後，已撤回上個月提出的提案。它表示無法確定此次收購的財務回報是否符合其資本配置框架。
Write to Stuart Condie at stuart.condie@wsj.com
通過 stuart.condie@wsj.com 寫信給 Stuart Condie
譯文內容由第三人軟體翻譯。